wellrank.ai
Prometrium logo

Prometrium

First cited by AI Jun 11, 2026
prometrium.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

Prometrium is losing the AEO war.

Not cited in a single tracked AI answer since Jun 13, 2026, down from a peak of 17% visibility in menopause and women's health on Jun 13, 2026. This page and its history stay public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Prometrium, through Jun 14, 2026.

0.0%

Last cited Jun 13, 2026 · peak 17% on Jun 13

By engine

Where Prometrium is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 7 positive mentions
  • 3 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Prometrium

ChatGPTJun 13, 2026, 11:06 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” hormones are molecules formulated to be chemically identical to the hormones your body makes (usually estradiol and progesterone). “Standard” HRT (hormone replacement therapy) includes both bioidentical (FDA‑approved) products and older synthetic or animal‑derived products; the main practical difference most people face is whether the product is an FDA‑reviewed drug or a custom‑compounded preparation from a pharmacy. There’s no good evidence that custom‑compounded “bioidentical hormone therapy” is safer or more effective than FDA‑approved HRT. Compounded products can have variable potency and lack FDA oversight. What each term means Bioidentical hormones: chemically identical to human hormones (example: 17β‑estradiol, micronized progesterone). These can be made as FDA‑approved products (tablets, patches, gels, vaginal rings) or as custom compounds from compounding pharmacies. Standard HRT: a broader category that includes FDA‑approved estradiol products (patches, gels, pills) and FDA‑approved micronized progesterone, synthetic progestins (e.g., medroxyprogesterone acetate) and animal‑derived estrogens (e.g., conjugated equine estrogens). These are manufactured drugs with standardized dosing and safety testing. Examples (brand names and why they matter) FDA‑approved, bioidentical examples: Prometrium (micronized progesterone) — FDA‑approved bioidentical progesterone used to protect the uterus when systemic estrogen is given. Estradiol patches/gels: Vivelle‑Dot, Climara, Alora — deliver 17β‑estradiol transdermally and have standardized dosing. Bijuva — an FDA‑approved combined oral capsule containing estradiol and progesterone (bioidentical combination). Vaginal products: Estrace cream, Vagifem tablets, Estring/Femring (vaginal ring/locally acting estradiol) — useful for local symptoms with lower systemic exposure. Non‑bioidentical / synthetic examples: Premarin (conjugated equine estrogens) — animal‑derived estrogen mixture, historically common. Provera (medroxyprogesterone acetate) — synthetic progestin. Compounded “bioidentical” creams or troches: made by compounding pharmacies to a custom dose. These are not FDA‑approved and product strength/purity can vary. If you choose this route, use a PCAB‑accredited compounding pharmacy (look up PCAB accreditation). Examples of well‑known compounding suppliers/pharmacies in the U.S. include Wedgewood Pharmacy and Fagron (as suppliers/compounding networks) — but check current accreditation and reputation locally. Safety, evidence, and regulation FDA‑approved HRT products have known dosages, standardized manufacturing, and have been evaluated for quality and safety. Long‑term risks (breast cancer, cardiovascular disease, stroke, blood clots) depend on the type of hormone, dose, route (oral vs transdermal), whether progesterone is given, and your personal risk factors. The Women’s Health Initiative (WHI) showed increased risks with combined conjugated equine estrogen + medroxyprogesterone in older participants. Risk profiles differ with estradiol vs conjugated equine estrogens and with micronized progesterone vs synthetic progestins. Compounded bioidenticals: proponents claim “natural” = safer, but there’s no high‑quality evidence that compounded BHRT reduces long‑term risks. Because compounded products aren’t FDA‑reviewed, potency and purity can be inconsistent and they may lack safety data. Testing and monitoring Beware of clinics that base dosing on saliva tests or single spot hormone levels — hormone levels fluctuate and those tests are not reliable for routine dosing. Appropriate approach: evaluate symptoms, medical history, family history (breast cancer, clotting disorders), baseline screening (mammogram, blood pressure, lipids, glucose as needed), then choose a therapy and monitor symptoms and side effects regularly. Use the lowest effective dose for the shortest needed time, and use uterine protection (progesterone or a progestin) if you have a uterus and take systemic estrogen. Practical guidance / when to prefer one option If you want the assurance of standardized dosing and known safety data, choose FDA‑approved products (e.g., estradiol patches, oral estradiol, Prometrium, Bijuva). Consider local vaginal estrogen (Estrace cream, Vagifem, Estring) for primarily vaginal dryness/urginal symptoms — these have lower systemic exposure. If you have unusual needs (allergies to excipients, very specific dose requests), a compounding pharmacy can be considered — but insist on a reputable, PCAB‑accredited pharmacy and understand the tradeoffs (no FDA approval, variable evidence). Discuss the choice with a clinician experienced in menopause/HRT care (board‑certified gynecologist or endocrinologist). Trusted resources: North American Menopause Society (NAMS), Mayo Clinic, Cleveland Clinic for patient information and evidence‑based guidance. Bottom line “Bioidentical” describes the molecular structure of the hormone; the clinically important distinction is whether the product is an FDA‑approved, standardized medication or a custom, non‑FDA‑regulated compounded product. FDA‑approved bioidentical options (Prometrium, estradiol patches/creams, Bijuva) give predictable dosing and safety data; compounded BHRT may be useful in select cases but carries more uncertainty. Talk with a clinician about your symptoms, risks, and monitoring plan before starting HRT.

Mentioned in position 1 of 13

Read full answer with sources →
ClaudeJun 13, 2026, 11:06 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone medications that may include: Synthetic hormones (like medroxyprogesterone acetate) or Horse-derived estrogens (like Premarin, from pregnant mare urine) Consistent, tested dosing Bioidentical Hormones Hormones chemically identical to those your body naturally produces, derived from plant sources (soy/yams). Two Categories of Bioidentical Options FDA-Approved Bioidentical Products (generally recommended) Estradiol patches – Vivelle-Dot, Climara Estradiol gels – EstroGel, Divigel Progesterone – Prometrium (oral capsule) These have standardized dosing and safety testing Compounded Bioidentical Hormones (more controversial) Custom-mixed by compounding pharmacies Often marketed as "natural" and personalized Not FDA-approved for safety/efficacy Quality can vary significantly between pharmacies Key Considerations FDA-approved bioidentical options offer the best of both worlds - natural molecular structure with proven safety data Most major medical organizations do not recommend compounded versions over regulated alternatives Always consult an endocrinologist or menopause specialist for personalized guidance The marketing around "bioidentical" can be misleading - FDA-approved options are your safest starting point.

Mentioned in position 6 of 6

Read full answer with sources →
ChatGPTJun 12, 2026, 10:19 UTC
BHRT vs traditional HRT: which should I ask for and where?

Short answer Start by talking with a clinician (your gynecologist or a menopause specialist) about your symptoms, health risks and goals. In most cases I’d ask first about FDA‑approved, “bioidentical” estradiol and progesterone options (transdermal estradiol patch, low‑dose vaginal estrogen for local symptoms, and micronized progesterone for endometrial protection). These have known dosing, manufacturing oversight and better safety data than custom‑compounded products. Consider compounded (“BHRT”) only after a careful discussion about risks/benefits and only from a PCAB‑accredited compounding pharmacy if you and your clinician decide you truly need a custom formulation. What “BHRT” and “traditional HRT” mean Traditional HRT usually refers to FDA‑approved products (oral or transdermal estradiol; conjugated estrogens; progestins such as medroxyprogesterone acetate; micronized progesterone). Many FDA‑approved estradiol and progesterone products are chemically identical to human hormones (“bioidentical”). “BHRT” commonly means custom‑compounded hormones made to order (variable doses/combination/forms). These are not FDA‑approved, have variable quality among pharmacies, and have limited long‑term safety data. Key pros/cons FDA‑approved HRT (recommended first): Pros: regulated manufacturing, consistent dosing, clinical trial and safety data, insurance coverage often available. Cons: fixed doses/forms may not suit every patient’s preference. Compounded BHRT: Pros: customized dose/form (cream, troche, unusual combos) — sometimes helpful if you cannot tolerate standard formulations. Cons: less regulation, variable potency/purity, limited evidence on long‑term safety and efficacy, insurance usually won’t cover. Specific products to consider asking about Transdermal estradiol patches (lower VTE risk than some oral estrogens): Vivelle‑Dot, Climara. Oral estradiol (bioidentical): Estrace. Vaginal/local products for genitourinary symptoms: Vagifem (tablet), Estring (ring), low‑dose estradiol creams/gels. Micronized progesterone (bioidentical for endometrial protection): Prometrium. Avoid automatically requesting “natural” or unspecified BHRT — ask whether the prescription is FDA‑approved and what evidence supports it. When BHRT might be reasonable You’ve tried standard, FDA‑approved therapy and have side effects or need a dose/form not commercially available; or you have a documented intolerance to available preparations. Even then: insist on a PCAB‑accredited compounding pharmacy and a clear plan for monitoring and follow‑up. Where to go / whom to ask Start with your primary care doctor or gynecologist. If your case is complex or you want specialized care, see a menopause clinician. Use these resources: North American Menopause Society (NAMS) — “Find a Menopause Practitioner” tool to locate NAMS‑certified clinicians. NAMS clinicians are experienced in individualized HRT decisions. Major academic centers/menopause clinics: Mayo Clinic, Cleveland Clinic, UCSF Menopause Program — good if you want a second opinion or complex-risk assessment. If you choose compounding, use a PCAB‑accredited compounding pharmacy (search PCAB accreditee list) — this reduces but does not eliminate quality concerns. What to ask your clinician (bring this list) What are the benefits and risks for me specifically (age, family history of breast cancer, clotting/cardiac history)? Which route is best (patch, pill, topical, vaginal) and why? Can you explain the evidence comparing transdermal estradiol + micronized progesterone vs oral estrogen + synthetic progestin for my risks? If I want “bioidentical” hormones, which FDA‑approved options are bioidentical? If you suggest compounded BHRT, why and from which accredited pharmacy? How will we monitor symptoms, side effects, and safety (follow‑up schedule, labs, mammograms)? Bottom line recommendation Ask first for a personalized plan from a knowledgeable clinician and consider FDA‑approved, bioidentical estradiol (prefer transdermal if clot risk is a concern) plus micronized progesterone if you have a uterus. Reserve compounded BHRT only after careful discussion and, if used, get it from a PCAB‑accredited pharmacy with close follow‑up. If you want, tell me: your age, menopausal symptoms, major medical history (breast clotting disease, heart disease, stroke, liver disease, cancer), and whether you prefer pills, patches, or topical treatments — I can suggest a specific conversation script and which exact product to request.

Mentioned in position 6 of 10

Read full answer with sources →
ChatGPTJun 12, 2026, 10:16 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Bioidentical hormones can be safe and effective when prescribed and monitored by a clinician, but the safety depends on which products are used, who prescribes them, and your personal health risks. Major medical societies caution against custom-compounded “bioidentical” mixtures and recommend FDA‑approved formulations when hormone therapy is needed. Key points doctors and medical societies emphasize “Bioidentical” simply means the molecule is chemically identical to human hormones (e.g., estradiol, progesterone). That label does not guarantee safety or superiority. FDA‑approved bioidentical products (standard prescription estradiol, micronized progesterone) are regulated for dose, purity and labeling. These are the preferred option for most clinicians. Custom-compounded BHRT made by compounding pharmacies is a concern because of inconsistent dosing, lack of standard testing, and weak evidence for claimed advantages. The FDA, ACOG, Endocrine Society and North American Menopause Society (NAMS) have warned about these issues. Risks seen with hormone therapy (both conventional and bioidentical) include increased risk of blood clots, stroke, and — depending on type/duration — possible effects on breast cancer risk and cardiovascular outcomes. Benefits include relief of hot flashes, vaginal symptoms, and bone protection. Individual risk/benefit depends on age, years since menopause, personal/family history of clotting, breast cancer, heart disease, etc. Practical clinical points doctors use If you have a uterus, you need progestogen with systemic estrogen to prevent endometrial hyperplasia. Transdermal estradiol (patches/gels) is often chosen because some evidence suggests lower risk of venous thromboembolism than oral estrogen. Micronized progesterone (versus some synthetic progestins) is preferred by many clinicians for certain safety/tolerability reasons. Routine saliva hormone testing to dose BHRT is not supported by evidence; serum testing and symptom-guided dosing are usual approaches. Testosterone for women can help low libido in selected cases but is generally off‑label and requires specialist oversight; compounded testosterone is commonly used but evidence is limited. FDA‑approved products commonly used (examples clinicians often prescribe) Estradiol (oral): Estrace — FDA‑approved estradiol tablet for menopausal symptoms. Estradiol patches: Vivelle‑Dot, Climara, Alora — transdermal patches give steady dosing and may lower clot risk. Local vaginal products: Estring (ring), Vagifem (vaginal tablet) — treat genitourinary symptoms with low systemic exposure. Micronized progesterone: Prometrium — an FDA‑approved “bioidentical” progesterone many doctors prefer. Testosterone: no widely accepted FDA product labeled for general female libido therapy in the U.S.; some clinicians prescribe low‑dose male formulations off‑label or refer to specialists. Services and resources to consider See a menopause specialist or a clinician trained in hormone management: centers at Mayo Clinic, Cleveland Clinic, or a NAMS‑recognized menopause practitioner are good choices. NAMS (North American Menopause Society) — evidence‑based guidance and clinician directory. If you prefer telemedicine, look for telehealth clinics with certified menopause providers (e.g., some services within Maven Clinic or large academic centers’ telehealth programs). What you can do next Talk with your primary care doctor, gynecologist or a menopause specialist about symptoms and your health history (clotting, heart disease, breast cancer). Ask for FDA‑approved options first (estradiol and micronized progesterone) and discuss routes (transdermal vs oral). Avoid compounded BHRT unless there is a clear medical reason and the compounding pharmacy is accredited and your prescriber documents why a custom product is necessary. Get baseline screening (mammogram as appropriate, blood pressure, discuss clotting history) and plan follow‑up to monitor benefit and side effects. If you want, tell me your age, symptoms, medical history (especially personal/family clotting, breast cancer, cardiovascular disease), and whether you’ve used hormones before — I can give more tailored information and suggest specific questions to bring to your clinician.

Mentioned in position 7 of 10

Read full answer with sources →
ClaudeJun 12, 2026, 10:16 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT): What You Should Know What Doctors Generally Say Medical opinion is mixed and nuanced: Mainstream medical organizations (like the FDA and Endocrine Society) have concerns: Compounded BHRT lacks rigorous safety testing "Natural" doesn't automatically mean safer Marketing claims often outpace the evidence Many practitioners do support FDA-approved bioidentical options, noting they may have a favorable safety profile compared to synthetic hormones. The Important Distinction Type Examples Status FDA-approved bioidenticals Estradiol patches, Prometrium Tested, regulated Custom compounded BHRT Pellets, custom creams Less regulated, variable quality Reputable Options Doctors Often Recommend Bijuva - FDA-approved estradiol/progesterone combo Prometrium - bioidentical progesterone pill Vivelle-Dot - estradiol patch, widely prescribed Menopause Society (NAMS) certified practitioners for guidance Bottom Line Consult a board-certified endocrinologist or OB-GYN Risks vary by age, health history, and hormone type The Menopause Society (nams.org) has a provider finder tool Would you like more detail on any specific aspect?

Mentioned in position 2 of 3

Read full answer with sources →
Google AIJun 12, 2026, 10:16 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT) is a complex topic, and its safety and effectiveness are subjects of ongoing discussion and research within the medical community. It's important to understand what BHRT is and what doctors generally say about it. What is BHRT? BHRT uses hormones that are chemically identical to the hormones produced by the human body, such as estrogen, progesterone, and testosterone. These hormones are derived from plant sources, like soy or yams, and are then synthesized in a lab to match the molecular structure of human hormones. This is in contrast to some traditional hormone therapies that use hormones derived from animal sources, which may have slightly different molecular structures. What Doctors Say About BHRT: The medical community's views on BHRT are nuanced and often depend on the specific hormones used, the dosage, the individual patient's health profile, and the intended use. Here's a general overview of what doctors say: Potential Benefits: Many doctors acknowledge that BHRT can be effective in treating symptoms associated with hormone imbalances, particularly for women going through menopause. These symptoms can include: Hot flashes and night sweats Vaginal dryness and pain during intercourse Sleep disturbances Mood swings and irritability Decreased libido Bone loss (osteoporosis) Safety Concerns and Risks: Like any form of hormone therapy, BHRT is not without potential risks. Doctors often emphasize that these risks can vary based on the type of hormone, the dose, and individual health factors. Some of the potential concerns include: Blood Clots: Estrogen therapy, in general, can increase the risk of blood clots. Stroke and Heart Disease: While earlier studies on synthetic hormones raised concerns, research on BHRT is more mixed. Some studies suggest that BHRT, particularly when initiated early in menopause, may not carry the same increased cardiovascular risk as older hormone therapies, but this is still an area of active research. Certain Cancers: The link between hormone therapy and cancer risk, particularly breast cancer, is complex. The type of hormone (estrogen alone vs. estrogen plus progesterone), duration of use, and individual risk factors play a significant role. Doctors often advise careful consideration and monitoring for those with a personal or family history of certain cancers. Endometrial Cancer: For women who still have a uterus, estrogen therapy without progesterone can increase the risk of endometrial cancer. Progesterone is typically prescribed alongside estrogen in these cases to protect the uterine lining. Individualized Treatment is Key: A common theme among doctors is that BHRT should be highly individualized. This means: Thorough Medical Evaluation: Doctors will conduct a comprehensive medical history, physical examination, and potentially blood tests to assess hormone levels and overall health. Personalized Dosing: The "one-size-fits-all" approach is generally avoided. Doses are tailored to the individual's needs and symptom presentation. Monitoring: Regular follow-up appointments are crucial to monitor for effectiveness, side effects, and adjust treatment as needed. Compounded vs. FDA-Approved BHRT: It's important to distinguish between compounded BHRT and FDA-approved BHRT. FDA-Approved BHRT: Brands like Estrace (estradiol), Prometrium (progesterone), and Testim (testosterone) are FDA-approved and have undergone rigorous testing for safety and efficacy. Many doctors prefer prescribing these due to standardized dosing and quality control. Compounded BHRT: These are custom-made preparations from a compounding pharmacy. While they can offer flexibility in dosing and combinations, their quality and standardization can vary, which is why some doctors express caution. What to Consider When Discussing BHRT with Your Doctor: Your Symptoms: Be specific about what you're experiencing. Your Medical History: Disclose any past or current health conditions, including cancer, heart disease, blood clots, migraines, liver disease, or gallbladder problems. Your Family History: Share any relevant family history of medical conditions. Your Lifestyle: Factors like smoking, alcohol consumption, and exercise habits can influence treatment decisions. Your Goals: What do you hope to achieve with BHRT? In Conclusion: BHRT can be a safe and effective treatment option for managing hormone deficiencies and their associated symptoms for many individuals, but it's not a universal solution and carries potential risks. The consensus among most healthcare professionals is that BHRT should only be used when medically indicated, prescribed by a qualified healthcare provider, and closely monitored. If you are considering BHRT, it is essential to have an in-depth conversation with your doctor. They can help you weigh the potential benefits against the risks based on your unique health profile and guide you toward the most appropriate treatment plan, which may or may not involve bioidentical hormones.

Mentioned in position 2 of 3

Read full answer with sources →

Public AI visibility history

Daily rank of Prometrium on our buyer intent questions, per category. A dash means the engines did not cite Prometrium at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13Jun 14
Menopause and women's health#33#9
BHRT#11

TL;DR

Prometrium is the brand name for micronized progesterone manufactured by AbbVie, used primarily in hormone therapy for menopausal women and in fertility support. It is a prescription-only oral capsule and is one of the few FDA-approved bioidentical progesterone products available in the United States. According to WellRank's latest index, Prometrium ranks eighth in AI-generated answers about bioidentical hormone replacement therapy, capturing 12 percent visibility, with five of eight tracked AI mentions carrying a positive tone.

Company Overview

Prometrium is a prescription pharmaceutical brand currently owned and marketed by AbbVie, a publicly traded global biopharmaceutical company headquartered in North Chicago, Illinois. The product itself is micronized progesterone in a peanut oil-based oral capsule, regulated and approved by the FDA. AbbVie markets Prometrium as part of its broader women's health portfolio, selling through licensed pharmacies and healthcare providers rather than direct-to-consumer retail.

Product Features

  • FDA-approved micronized progesterone oral capsules (100 mg and 200 mg strengths)
  • Indicated for prevention of endometrial hyperplasia in postmenopausal women using estrogen
  • Indicated for secondary amenorrhea in women of reproductive age
  • Bioidentical molecular structure chemically identical to naturally produced human progesterone
  • Peanut oil-based formulation, which contraindicates use in patients with peanut allergies
  • Available only by prescription through licensed U.S. pharmacies

Target Market

Prometrium primarily serves postmenopausal women in the United States who are using estrogen therapy and require progestogen protection for the uterine lining, as well as women of reproductive age experiencing secondary amenorrhea. It is prescribed by OB-GYNs, endocrinologists, and primary care physicians. The product is also used off-label in fertility protocols, broadening its reach to reproductive-age women undergoing assisted reproduction.

Buyer Personas

  • A perimenopausal or postmenopausal woman prescribed combination hormone therapy who prefers a bioidentical progesterone option over synthetic progestins.
  • A reproductive-age woman diagnosed with secondary amenorrhea seeking an FDA-approved progesterone treatment to restore regular menstrual cycles.
  • A fertility patient working with a reproductive endocrinologist who incorporates micronized progesterone into an IVF or other assisted-reproduction protocol.
  • A health-conscious midlife woman researching hormone therapy options and prioritizing bioidentical formulations recommended by her gynecologist or a menopause specialist.

Funding & Performance

Prometrium is a product of AbbVie (NYSE: ABBV), a large-cap publicly traded biopharmaceutical company. Revenue attributable specifically to Prometrium is not broken out separately in AbbVie's public financial disclosures.

Recent Developments

AbbVie has continued to maintain Prometrium as part of its established women's health portfolio. Broader industry interest in bioidentical hormone therapy has grown alongside increased attention from organizations such as the North American Menopause Society to evidence-based menopause care, which has kept FDA-approved bioidentical options like Prometrium in clinical and public conversation. No major new formulations or indications have been widely reported in recent periods.

Competitive Landscape

In WellRank's co-mention data, Prometrium appears most frequently alongside estrogen-based hormone therapies such as Estrace, Vivelle-Dot, Climara, and Vagifem, reflecting its role as the progesterone component in combination menopause regimens. It also surfaces near Estring and Testim, indicating AI engines contextualize it within the wider hormone therapy category. Its primary competition comes from synthetic progestins included in combination pills and patches, as well as compounded bioidentical progesterone preparations, though Prometrium holds the distinction of being the only FDA-approved oral micronized progesterone product in the U.S. market.

Mentioned alongside

Brands AI engines recommend in the same breath. Your real competitive set.

User Sentiment

Among the eight AI-engine mentions tracked by WellRank, five are positive and three are neutral, with no mixed or cautious characterizations recorded, suggesting AI systems consistently frame Prometrium as a credible, established clinical option. Public sentiment in patient communities tends to be favorable among women who report tolerating bioidentical progesterone better than synthetic progestins, though individual experiences vary. Authoritative sources such as the Mayo Clinic reference progesterone therapy in menopause guidance, contributing to the product's relatively trustworthy positioning in AI-generated health answers.

Pricing

Prometrium is a prescription drug and its cost depends on insurance coverage, pharmacy, and dosage. List prices are publicly available through pharmacy benefit tools but vary considerably; patients with insurance may pay a copay while uninsured patients pay significantly more. Exact out-of-pocket figures are not published in a stable, universally applicable form, so pricing is best described as variable and coverage-dependent.

Sources cited around Prometrium

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Prometrium weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Prometrium? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.